Why the 25(OH)D curve flattens at higher doses
Serum 25-hydroxyvitamin D, the standard marker of vitamin D status, rises as supplemental dose increases, but the relationship is not linear. At low baseline levels each additional unit of intake raises the marker substantially; as stores fill, the same increment moves the level much less, producing a flattening curve. Roughly speaking the response is steeper in deficient individuals and shallower in those already replete, which is why two people on the same dose can land at very different blood levels.
Reported plateau ranges vary between studies and laboratories, so any single number such as a plateau around 60 to 80 nanograms per millilitre should be read as an approximate, study-dependent figure rather than a fixed threshold. Units also matter: the same value is often expressed in nanomoles per litre, about 2.5 times the ng/mL number.
Where benefit, sufficiency, and toxicity sit on the axis
The lower end of the curve is where correcting deficiency yields the clearest benefit for bone health. Once sufficiency is reached, evidence for additional benefit from pushing levels higher weakens. Toxicity is driven by hypercalcaemia and is associated with sustained very high 25(OH)D, often cited above roughly 150 ng/mL, though the harmful threshold is not perfectly defined and depends on duration and calcium intake.
This is general educational information, not medical advice. Optimal vitamin D level, dose, and the need for monitoring differ by individual; consult a qualified healthcare professional and use blood testing rather than self-selecting a high dose.